-
1
-
-
12444334564
-
Prevalence of neurofibromatosis 1 in German children at elementary school enrollment
-
Lammert M, Friedman J, Kluwe L, et al. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol 2005;141(1):71-74
-
(2005)
Arch Dermatol
, vol.141
, Issue.1
, pp. 71-74
-
-
Lammert, M.1
Friedman, J.2
Kluwe, L.3
-
3
-
-
65449184541
-
Neurofibromatosis type 1: Its association with the Ras/MAPK pathway syndromes
-
Bennett E, Thomas NS, Upadhyaya M. Neurofibromatosis type 1: its association with the Ras/MAPK pathway syndromes. J Paeditr Neurol 2009 7:1-5
-
(2009)
J Paeditr Neurol
, vol.7
, pp. 1-5
-
-
Bennett, E.1
Thomas, N.S.2
Upadhyaya, M.3
-
4
-
-
33847316896
-
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
-
Ferner R, Huson S, Thomas N, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 2007;44(2):81-88
-
(2007)
J Med Genet
, vol.44
, Issue.2
, pp. 81-88
-
-
Ferner, R.1
Huson, S.2
Thomas, N.3
-
5
-
-
0037442427
-
Progesterone receptor expression in neurofibromas
-
Mclaughlin M, Jacks T. Progesterone receptor expression in neurofibromas. Cancer Res 2003;63(4):752-755
-
(2003)
Cancer Res
, vol.63
, Issue.4
, pp. 752-755
-
-
McLaughlin, M.1
Jacks, T.2
-
6
-
-
62149143322
-
Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas
-
Tucker T, Friedman JM, Friedrich RE, et al. Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas. J Med Genet 2009;46:81-85
-
(2009)
J Med Genet
, vol.46
, pp. 81-85
-
-
Tucker, T.1
Friedman, J.M.2
Friedrich, R.E.3
-
7
-
-
33947530697
-
NF1 plexiformneurofibroma growth rate by volumetric MRI: Relationship to age and body weight
-
Dombi E, Solomon J, Gillespie A, et al. NF1 plexiformneurofibroma growth rate by volumetric MRI: relationship to age and body weight. Neurology 2007;68(9):643-647
-
(2007)
Neurology
, vol.68
, Issue.9
, pp. 643-647
-
-
Dombi, E.1
Solomon, J.2
Gillespie, A.3
-
8
-
-
0036096489
-
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
-
Evans D, Baser M, Mcgaughran J, et al. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 2002;39(5):311-314
-
(2002)
J Med Genet
, vol.39
, Issue.5
, pp. 311-314
-
-
Evans, D.1
Baser, M.2
McGaughran, J.3
-
9
-
-
65349086151
-
Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1
-
Brems H, Beert E, De Ravel T, Legius E. Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol 2009;10(5):508-515
-
(2009)
Lancet Oncol
, vol.10
, Issue.5
, pp. 508-515
-
-
Brems, H.1
Beert, E.2
De Ravel, T.3
Legius, E.4
-
10
-
-
84870227493
-
The neurofibromatosis: Classification, clinical features and genetic counselling
-
Kaufmann D, editor, Basel, Karger Monograph Hum Genet
-
Huson SM. The neurofibromatosis: classification, clinical features and genetic counselling. In: Kaufmann D, editor, Neurofibromatoses, Basel, Karger Monograph Hum Genet 2008;16:1-20
-
(2008)
Neurofibromatoses
, vol.16
, pp. 1-20
-
-
Huson, S.M.1
-
12
-
-
34548328245
-
Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype
-
Brems H, Chmara M, Sahbatou M, et al. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 2007;39(9):1120-1126
-
(2007)
Nat Genet
, vol.39
, Issue.9
, pp. 1120-1126
-
-
Brems, H.1
Chmara, M.2
Sahbatou, M.3
-
13
-
-
50649111364
-
Constitutional mismatch repair-deficiency syndrome: Have we so far seen only the tip of an iceberg?
-
Wimmer K, Etzler J. Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? Hum Genet 2008;124(2):105-122
-
(2008)
Hum Genet
, vol.124
, Issue.2
, pp. 105-122
-
-
Wimmer, K.1
Etzler, J.2
-
14
-
-
29144462041
-
Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations
-
Bandipalliam P. Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations. Fam Cancer 2005;4(4):323-333
-
(2005)
Fam Cancer
, vol.4
, Issue.4
, pp. 323-333
-
-
Bandipalliam, P.1
-
15
-
-
34547796898
-
Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1
-
Maertens O, De Schepper S, Vandesompele J, et al. Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1. Am J Hum Genet 2007;81(2):243-251
-
(2007)
Am J Hum Genet
, vol.81
, Issue.2
, pp. 243-251
-
-
Maertens, O.1
De Schepper, S.2
Vandesompele, J.3
-
16
-
-
34547657613
-
The use of anterolateral bowing of the lower leg in the diagnostic criteria for neurofibromatosis type 1
-
Stevenson D, Viskochil D, Schorry E, et al. The use of anterolateral bowing of the lower leg in the diagnostic criteria for neurofibromatosis type 1. Genet Med 2007;9(7):409-412
-
(2007)
Genet Med
, vol.9
, Issue.7
, pp. 409-412
-
-
Stevenson, D.1
Viskochil, D.2
Schorry, E.3
-
17
-
-
0025369709
-
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
-
Viskochil D, Buchberg A, Xu G, et al. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 1990;62(1):187-192
-
(1990)
Cell
, vol.62
, Issue.1
, pp. 187-192
-
-
Viskochil, D.1
Buchberg, A.2
Xu, G.3
-
18
-
-
84870201398
-
NF1 gene structure and NF1 genotype/phenotype correlations
-
Kaufmann D, editor, Basel, Karger. MonogrHum Genet
-
Upadhyaya M. NF1 gene structure and NF1 genotype/phenotype correlations. In: Kaufmann D, editor, Neurofibromatoses, Basel, Karger. MonogrHum Genet 2008;16:46-62
-
(2008)
Neurofibromatoses
, vol.16
, pp. 46-62
-
-
Upadhyaya, M.1
-
19
-
-
0035936783
-
NF1 tumor suppressor gene function: Narrowing the GAP
-
Cichowski K, Jacks T. NF1 tumor suppressor gene function: narrowing the GAP. Cell 2001;104(4):593-604
-
(2001)
Cell
, vol.104
, Issue.4
, pp. 593-604
-
-
Cichowski, K.1
Jacks, T.2
-
20
-
-
33947429718
-
Neurofibromatosis
-
Mcclatchey A. Neurofibromatosis. Annu Rev Pathol 2007;2:191-216
-
(2007)
Annu Rev Pathol
, vol.2
, pp. 191-216
-
-
McClatchey, A.1
-
21
-
-
79959618575
-
Structure and function of neurofibromin
-
Kaufmann D, editor, Basel, Karger. MonogrHum Genet
-
Welti S, D'angelo I, Scheffzek. Structure and function of neurofibromin. In: Kaufmann D, editor, Neurofibromatoses, Basel, Karger. MonogrHum Genet 2008;16:46-62
-
(2008)
Neurofibromatoses
, vol.16
, pp. 46-62
-
-
Welti, S.1
D'Angelo, I.2
Scheffzek3
-
22
-
-
20844435467
-
The NF1 tumor suppressor critically regulates TSC2 and mTOR
-
Johannessen C, Reczek E, James M, et al. The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Natl Acad Sci USA 2005;102(24):8573- 8578
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, Issue.24
, pp. 8573-8578
-
-
Johannessen, C.1
Reczek, E.2
James, M.3
-
24
-
-
0002056513
-
The mutation spectrum in neurofibromatosis type 1 and its underlying mechanism
-
Chapter 5. In: Upadhyaya M, Cooper D, editors. BIOS Scientific, Oxford
-
Upadhyaya M, Cooper DN. The mutation spectrum in neurofibromatosis type 1 and its underlying mechanism. Chapter 5. In: Upadhyaya M, Cooper D, editors, Neurofibromatosis type 1: from genotype to phenotype. BIOS Scientific, Oxford; 1998. p. 65-87
-
(1998)
Neurofibromatosis Type 1: From Genotype to Phenotype
, pp. 65-87
-
-
Upadhyaya, M.1
Cooper, D.N.2
-
25
-
-
77953954245
-
-
Available from
-
Available from: http://www.hgmd.org
-
-
-
-
26
-
-
84870198562
-
NF1 Mutational spectrum
-
Kaufmann D, editor, Basel, Karger. MonogrHumGenet
-
Messiaen LM, Wimmer K. NF1 Mutational spectrum. In: Kaufmann D, editor, Neurofibromatoses, Basel, Karger. MonogrHumGenet 2008;16:63-77
-
(2008)
Neurofibromatoses
, vol.16
, pp. 63-77
-
-
Messiaen, L.M.1
Wimmer, K.2
-
27
-
-
1042299966
-
Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene
-
Kluwe L, Siebert R, Gesk S, et al. Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene. Hum Mutat 2004;23(2):111-116
-
(2004)
Hum Mutat
, vol.23
, Issue.2
, pp. 111-116
-
-
Kluwe, L.1
Siebert, R.2
Gesk, S.3
-
28
-
-
32544441269
-
Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients
-
Wimmer K, Yao S, Claes K, et al. Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients. Genes Chromosomes Cancer 2006;45(3):265-276
-
(2006)
Genes Chromosomes Cancer
, vol.45
, Issue.3
, pp. 265-276
-
-
Wimmer, K.1
Yao, S.2
Claes, K.3
-
29
-
-
0033966774
-
Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1
-
Ars E, Serra E, García J, et al. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet 2000;9(2):237-247
-
(2000)
Hum Mol Genet
, vol.9
, Issue.2
, pp. 237-247
-
-
Ars, E.1
Serra, E.2
García, J.3
-
30
-
-
0028120348
-
Molecular basis of neurofibromatosis type 1 (NF1): Mutation analysis and polymorphisms in the NF1 gene
-
Upadhyaya M, Shaw D, Harper P. Molecular basis of neurofibromatosis type 1 (NF1): mutation analysis and polymorphisms in the NF1 gene. Hum Mutat 1994;4(2):83-101
-
(1994)
Hum Mutat
, vol.4
, Issue.2
, pp. 83-101
-
-
Upadhyaya, M.1
Shaw, D.2
Harper, P.3
-
31
-
-
0038481667
-
Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients
-
Ars E, Kruyer H, Morell M, et al. Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients. J Med Genet 2003;40(6):82
-
(2003)
J Med Genet
, vol.40
, Issue.6
, pp. 82
-
-
Ars, E.1
Kruyer, H.2
Morell, M.3
-
32
-
-
33847112447
-
Molecular diagnosis for NF1: 2 years experience
-
Griffiths S, Thompson P, Frayling I, et al. Molecular diagnosis for NF1: 2 years experience. Fam Cancer 2007;6(1):21-34
-
(2007)
Fam Cancer
, vol.6
, Issue.1
, pp. 21-34
-
-
Griffiths, S.1
Thompson, P.2
Frayling, I.3
-
33
-
-
0034267932
-
Segmental neurofibromatosis
-
Ruggieri M, Polizzi A. Segmental neurofibromatosis. J Neurosurg 2000;93(3):530-532
-
(2000)
J Neurosurg
, vol.93
, Issue.3
, pp. 530-532
-
-
Ruggieri, M.1
Polizzi, A.2
-
34
-
-
27144550883
-
Gonosomalmosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1
-
Consoli C, Moss C, Green S, et al. Gonosomalmosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1. J Invest Dermatol 2005;125(3):463-466
-
(2005)
J Invest Dermatol
, vol.125
, Issue.3
, pp. 463-466
-
-
Consoli, C.1
Moss, C.2
Green, S.3
-
35
-
-
77953948637
-
-
Available from
-
Available from: http://www.dh.gov.uk/
-
-
-
-
36
-
-
26444532012
-
Preimplantation genetic diagnosis for neurofibromatosis type 1
-
Spits C, De Rycke M, Van Ranst N, et al. Preimplantation genetic diagnosis for neurofibromatosis type 1. Mol Hum Reprod 2005;11(5):381-387
-
(2005)
Mol Hum Reprod
, vol.11
, Issue.5
, pp. 381-387
-
-
Spits, C.1
De Rycke, M.2
Van Ranst, N.3
-
37
-
-
0028082464
-
Deletions spanning the neurofibromatosis 1 gene: Identification and phenotype of five patients
-
Kayes L, Burke W, Riccardi V, et al. Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. Am J Hum Genet 1994;54(3):424-436
-
(1994)
Am J Hum Genet
, vol.54
, Issue.3
, pp. 424-436
-
-
Kayes, L.1
Burke, W.2
Riccardi, V.3
-
38
-
-
0031744843
-
Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay
-
Upadhyaya M, Ruggieri M, Maynard J, et al. Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay. Hum Genet 1998;102:591-597
-
(1998)
Hum Genet
, vol.102
, pp. 591-597
-
-
Upadhyaya, M.1
Ruggieri, M.2
Maynard, J.3
-
39
-
-
33845974480
-
An absence of cutaneousneurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): Evidence of a clinically significant NF1 genotype-phenotype correlation
-
Upadhyaya M, Huson S, Davies M, et al. An absence of cutaneousneurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet 2007;80(1):140-151
-
(2007)
Am J Hum Genet
, vol.80
, Issue.1
, pp. 140-151
-
-
Upadhyaya, M.1
Huson, S.2
Davies, M.3
-
40
-
-
39749145210
-
NF1 microduplication first clinical report: Association with mild mental retardation, early onset of baldness and dental enamel hypoplasia?
-
Grisart B, Rack K, Vidrequin S, et al. NF1 microduplication first clinical report: association with mild mental retardation, early onset of baldness and dental enamel hypoplasia? Eur J Hum Genet 2008;16(3):305-311
-
(2008)
Eur J Hum Genet
, vol.16
, Issue.3
, pp. 305-311
-
-
Grisart, B.1
Rack, K.2
Vidrequin, S.3
-
41
-
-
0037562897
-
NF1 mutations and clinical spectrum in patients with spinal neurofibromas
-
Kluwe L, Tatagiba M, Fünsterer C, Mautner V. NF1 mutations and clinical spectrum in patients with spinal neurofibromas. J Med Genet 2003;40(5):368-371
-
(2003)
J Med Genet
, vol.40
, Issue.5
, pp. 368-371
-
-
Kluwe, L.1
Tatagiba, M.2
Fünsterer, C.3
Mautner, V.4
-
42
-
-
70249117521
-
The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas
-
Upadhyaya M, Spurlock G, Kluwe L, et al. The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas. Neurogenetics 2009;10(3):251-263
-
(2009)
Neurogenetics
, vol.10
, Issue.3
, pp. 251-263
-
-
Upadhyaya, M.1
Spurlock, G.2
Kluwe, L.3
-
43
-
-
61849107166
-
A severe form of Noonan syndrome and autosomal dominant cafe-au-lait spots - Evidence for different genetic origins
-
Nystrom A, Ekvall S, Stromberg B, et al. A severe form of Noonan syndrome and autosomal dominant cafe-au-lait spots - evidence for different genetic origins. Acta Paediatr 2009;98(4):693-698
-
(2009)
Acta Paediatr
, vol.98
, Issue.4
, pp. 693-698
-
-
Nystrom, A.1
Ekvall, S.2
Stromberg, B.3
-
44
-
-
0027379865
-
An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): Evidence for modifying genes
-
Easton D, Ponder M, Huson S, Ponder B. An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet 1993;53(2):305-313
-
(1993)
Am J Hum Genet
, vol.53
, Issue.2
, pp. 305-313
-
-
Easton, D.1
Ponder, M.2
Huson, S.3
Ponder, B.4
-
45
-
-
33847613982
-
Nf1 expression is dependent on strain background: Implications for tumor suppressor haploinsufficiency studies
-
Hawes J, Tuskan R, Reilly K. Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies. Neurogenetics. 2007;8(2):121-130
-
(2007)
Neurogenetics
, vol.8
, Issue.2
, pp. 121-130
-
-
Hawes, J.1
Tuskan, R.2
Reilly, K.3
-
46
-
-
71749103918
-
Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome
-
Messiaen L, Yao S, Brems H, et al. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome. JAMA 2009;302(19):2111-2118
-
(2009)
JAMA
, vol.302
, Issue.19
, pp. 2111-2118
-
-
Messiaen, L.1
Yao, S.2
Brems, H.3
-
47
-
-
58149375379
-
Spred1 is required for synaptic plasticity and hippocampus-dependent learning
-
Denayer E, Ahmed T, Brems H, et al. Spred1 is required for synaptic plasticity and hippocampus-dependent learning. J Neurosci 2008;28(53):14443- 14449
-
(2008)
J Neurosci
, vol.28
, Issue.53
, pp. 14443-14449
-
-
Denayer, E.1
Ahmed, T.2
Brems, H.3
-
48
-
-
67650489624
-
SPRED1 mutations (Legius syndrome): Another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype
-
Spurlock G, Bennett E, Chuzhanova N, et al. SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype. J Med Genet 2009;46(7):431-437
-
(2009)
J Med Genet
, vol.46
, Issue.7
, pp. 431-437
-
-
Spurlock, G.1
Bennett, E.2
Chuzhanova, N.3
-
49
-
-
67650470276
-
SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype
-
Pasmant E, Sabbagh A, Hanna N, et al. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. J Med Genet 2009;46(7):425-430
-
(2009)
J Med Genet
, vol.46
, Issue.7
, pp. 425-430
-
-
Pasmant, E.1
Sabbagh, A.2
Hanna, N.3
-
50
-
-
56049088767
-
Clinical and molecular aspects of RAS related disorders
-
Denayer E, De Ravel T, Legius E. Clinical and molecular aspects of RAS related disorders. J Med Genet 2008;45(11):695-703
-
(2008)
J Med Genet
, vol.45
, Issue.11
, pp. 695-703
-
-
Denayer, E.1
De Ravel, T.2
Legius, E.3
-
51
-
-
33947594129
-
Hyperactive Ras in developmental disorders and cancer
-
Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer, Nat Rev Cancer 2007;7:295-308
-
(2007)
Nat Rev Cancer
, vol.7
, pp. 295-308
-
-
Schubbert, S.1
Shannon, K.2
Bollag, G.3
-
52
-
-
75149112680
-
Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back
-
Rauen K, Schoyer L, Mccormick F, et al. Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: from bedside to bench and back. Am J Med Genet A 2010;152A(1):4-24
-
(2010)
Am J Med Genet A
, vol.152 A
, Issue.1
, pp. 4-24
-
-
Rauen, K.1
Schoyer, L.2
McCormick, F.3
-
53
-
-
0016720617
-
The reaction of connective tissue fibers in the tumor of Recklinghausen's disease
-
Lassmann H, Gebhart W, Stockinger L. The reaction of connective tissue fibers in the tumor of Recklinghausen's disease. Virchows Arch B Cell Pathol 1975;19(2):167-177
-
(1975)
Virchows Arch B Cell Pathol
, vol.19
, Issue.2
, pp. 167-177
-
-
Lassmann, H.1
Gebhart, W.2
Stockinger, L.3
-
54
-
-
0024205976
-
Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis
-
Peltonen J, Jaakkola S, Lebwohl M, et al. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest 1988;59(6):760-771
-
(1988)
Lab Invest
, vol.59
, Issue.6
, pp. 760-771
-
-
Peltonen, J.1
Jaakkola, S.2
Lebwohl, M.3
-
55
-
-
30044443915
-
Tight junction proteins and perineurial cells in neurofibromas
-
Pummi K, Aho H, Laato M, et al. Tight junction proteins and perineurial cells in neurofibromas. J Histochem Cytochem 2006;54(1):53-61
-
(2006)
J Histochem Cytochem
, vol.54
, Issue.1
, pp. 53-61
-
-
Pummi, K.1
Aho, H.2
Laato, M.3
-
56
-
-
0034642298
-
Schwann cells harbor the somatic NF1 mutation in neurofibromas: Evidence of two different Schwann cell subpopulations
-
Serra E, Rosenbaum T, Winner U, et al. Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations. Hum Mol Genet 2000;9(20):3055-3064
-
(2000)
Hum Mol Genet
, vol.9
, Issue.20
, pp. 3055-3064
-
-
Serra, E.1
Rosenbaum, T.2
Winner, U.3
-
57
-
-
0015043748
-
Mutation and cancer: Statistical study of retinoblastoma
-
Knudson AJ. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68(4):820-823
-
(1971)
Proc Natl Acad Sci USA
, vol.68
, Issue.4
, pp. 820-823
-
-
Knudson, A.J.1
-
58
-
-
10744220011
-
Characterisation of somatic mutational spectrum of neurofibromatosis type (NF1) gene in neurofibromatosis patients with benign and malignant tumours
-
Upadhyaya M, Han S, Consoli C, Majounie E, et al. Characterisation of somatic mutational spectrum of neurofibromatosis type (NF1) gene in neurofibromatosis patients with benign and malignant tumours. Hum Mut 2004;23:134-146
-
(2004)
Hum Mut
, vol.23
, pp. 134-146
-
-
Upadhyaya, M.1
Han, S.2
Consoli, C.3
Majounie, E.4
-
59
-
-
38149064478
-
Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs)
-
Upadhyaya M, Kluwe L, Spurlock G, et al. Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs). Hum Mutat 2008;29(1):74-82
-
(2008)
Hum Mutat
, vol.29
, Issue.1
, pp. 74-82
-
-
Upadhyaya, M.1
Kluwe, L.2
Spurlock, G.3
-
60
-
-
0033864837
-
Loss of NF1 gene expression in NF1-associated pilocyticastrocytomas
-
Gutmann DH, Donahoe J, Brown T, et al. Loss of NF1 gene expression in NF1-associated pilocyticastrocytomas. Neuropathol Appl Neurobiol 2000;26:361-367
-
(2000)
Neuropathol Appl Neurobiol
, vol.26
, pp. 361-367
-
-
Gutmann, D.H.1
Donahoe, J.2
Brown, T.3
-
61
-
-
34447114512
-
Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1
-
Bausch B, Borozdin W, Mautner V, et al. Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. J Clin Endocrinol Metab 2007;92(7):2784-2792
-
(2007)
J Clin Endocrinol Metab
, vol.92
, Issue.7
, pp. 2784-2792
-
-
Bausch, B.1
Borozdin, W.2
Mautner, V.3
-
62
-
-
0030947237
-
Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders
-
Side L, Taylor B, Cayouette M, et al. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Engl J Med 1997;336(24):1713-1720
-
(1997)
N Engl J Med
, vol.336
, Issue.24
, pp. 1713-1720
-
-
Side, L.1
Taylor, B.2
Cayouette, M.3
-
63
-
-
33644781795
-
Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients
-
Maertens O, Prenen H, Debiec-Rychter M, et al. Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet 2006;15(6):1015-1023
-
(2006)
Hum Mol Genet
, vol.15
, Issue.6
, pp. 1015-1023
-
-
Maertens, O.1
Prenen, H.2
Debiec-Rychter, M.3
-
64
-
-
33847168544
-
Gastric carcinoid: Germline and somatic mutation of the neurofibromatosis type 1 gene
-
Stewart W, Traynor J, Cooke A, et al. Gastric carcinoid: germline and somatic mutation of the neurofibromatosis type 1 gene. Fam Cancer 2007;6(1):147-152
-
(2007)
Fam Cancer
, vol.6
, Issue.1
, pp. 147-152
-
-
Stewart, W.1
Traynor, J.2
Cooke, A.3
-
65
-
-
70349743969
-
Glomus tumors in neurofibromatosis type 1: Genetic, functional, and clinical evidence of a novel association
-
Brems H, Park C, Maertens O, et al. Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association. Cancer Res 2009;69(18):7393-7401
-
(2009)
Cancer Res
, vol.69
, Issue.18
, pp. 7393-7401
-
-
Brems, H.1
Park, C.2
Maertens, O.3
-
66
-
-
33745259022
-
Double inactivation of NF1 in tibialpseudarthrosis
-
Stevenson D, Zhou H, Ashrafi S, et al. Double inactivation of NF1 in tibialpseudarthrosis. Am J Hum Genet 2006;79(1):143-148
-
(2006)
Am J Hum Genet
, vol.79
, Issue.1
, pp. 143-148
-
-
Stevenson, D.1
Zhou, H.2
Ashrafi, S.3
-
67
-
-
0037012848
-
Neurofibromas in NF1: Schwann cell origin and role of tumor environment
-
Zhu Y, Ghosh P, Charnay P, et al. Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 2002;296(5569):920-922
-
(2002)
Science
, vol.296
, Issue.5569
, pp. 920-922
-
-
Zhu, Y.1
Ghosh, P.2
Charnay, P.3
-
68
-
-
54549095884
-
Nf1-dependent tumors require a microenvironment containing Nf1+/- and c-kit-dependent bone marrow
-
Yang F, Ingram D, Chen S, et al. Nf1-dependent tumors require a microenvironment containing Nf1+/- and c-kit-dependent bone marrow. Cell 2008;135(3):437-448
-
(2008)
Cell
, vol.135
, Issue.3
, pp. 437-448
-
-
Yang, F.1
Ingram, D.2
Chen, S.3
-
69
-
-
57749101397
-
NF1 loss disrupts Schwann cell-axonal interactions: A novel role for semaphorin 4F
-
Parrinello S, Noon L, Harrisingh M, et al. NF1 loss disrupts Schwann cell-axonal interactions: a novel role for semaphorin 4F. Genes Dev 2008;22(23):3335-3348
-
(2008)
Genes Dev
, vol.22
, Issue.23
, pp. 3335-3348
-
-
Parrinello, S.1
Noon, L.2
Harrisingh, M.3
-
70
-
-
65349141187
-
Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas
-
Le L, Shipman T, Burns D, Parada L. Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas. Cell Stem Cell 2009;4(5):453-463
-
(2009)
Cell Stem Cell
, vol.4
, Issue.5
, pp. 453-463
-
-
Le, L.1
Shipman, T.2
Burns, D.3
Parada, L.4
-
71
-
-
38549102668
-
The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells
-
Joseph N, Mosher J, Buchstaller J, et al. The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. Cancer Cell 2008;13(2):129-140
-
(2008)
Cancer Cell
, vol.13
, Issue.2
, pp. 129-140
-
-
Joseph, N.1
Mosher, J.2
Buchstaller, J.3
-
72
-
-
78649329027
-
Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: Correlation between histopathological, clinical and molecular findings
-
In press
-
Spurlock G, Knight S, Thomas NICK, et al. Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings J Cancer Res Clin Oncol 2010; In press
-
(2010)
J Cancer Res Clin Oncol
-
-
Spurlock, G.1
Knight, S.2
Thomas, N.I.C.K.3
-
73
-
-
39749203515
-
High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization
-
Mantripragada K, Spurlock G, Kluwe L, et al. High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization. Clin Cancer Res 2008;14(4):1015-1024
-
(2008)
Clin Cancer Res
, vol.14
, Issue.4
, pp. 1015-1024
-
-
Mantripragada, K.1
Spurlock, G.2
Kluwe, L.3
-
74
-
-
70349307184
-
Genome-wide high-resolution analysis of DNA copy number alterations in NF1-associated malignant peripheral nerve sheath tumors using 32K BAC array
-
Mantripragada K, De Stahl T, Patridge C, et al. Genome-wide high-resolution analysis of DNA copy number alterations in NF1-associated malignant peripheral nerve sheath tumors using 32K BAC array. Genes Chromosomes Cancer 2009;48(10):897-907
-
(2009)
Genes Chromosomes Cancer
, vol.48
, Issue.10
, pp. 897-907
-
-
Mantripragada, K.1
De Stahl, T.2
Patridge, C.3
-
75
-
-
1842610572
-
Recent advances in neurofibromatosis type 1
-
Arun D, Gutmann D. Recent advances in neurofibromatosis type 1. Curr Opin Neurol 2004;17(2):101-105
-
(2004)
Curr Opin Neurol
, vol.17
, Issue.2
, pp. 101-105
-
-
Arun, D.1
Gutmann, D.2
-
76
-
-
30144442616
-
Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications
-
Gottfried O, Viskochil D, Fults D, Couldwell W. Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications. Neurosurgery 2006;58(1):1-16
-
(2006)
Neurosurgery
, vol.58
, Issue.1
, pp. 1-16
-
-
Gottfried, O.1
Viskochil, D.2
Fults, D.3
Couldwell, W.4
-
77
-
-
73349118491
-
PTEN dosage is essential for neurofibroma development and malignant transformation
-
Gregorian C, Nakashima J, Dry S, et al. PTEN dosage is essential for neurofibroma development and malignant transformation. Proc Natl Acad Sci USA 2009;106(46):19479-19484
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, Issue.46
, pp. 19479-19484
-
-
Gregorian, C.1
Nakashima, J.2
Dry, S.3
-
78
-
-
0346059618
-
Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity
-
Bajenaru M, Hernandez M, Perry A, et al. Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. Cancer Res 2003;63(24):8573-8577
-
(2003)
Cancer Res
, vol.63
, Issue.24
, pp. 8573-8577
-
-
Bajenaru, M.1
Hernandez, M.2
Perry, A.3
-
79
-
-
57849109837
-
Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model
-
Alcantara Llaguno S, Chen J, Kwon C, et al. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 2009;15(1):45-56
-
(2009)
Cancer Cell
, vol.15
, Issue.1
, pp. 45-56
-
-
Alcantara Llaguno, S.1
Chen, J.2
Kwon, C.3
-
80
-
-
44849089702
-
Ptenhaploinsufficiency accelerates formation of high-grade astrocytomas
-
Kwon C, Zhao D, Chen J, et al. Ptenhaploinsufficiency accelerates formation of high-grade astrocytomas. Cancer Res 2008;68(9):3286-3294
-
(2008)
Cancer Res
, vol.68
, Issue.9
, pp. 3286-3294
-
-
Kwon, C.1
Zhao, D.2
Chen, J.3
-
82
-
-
33645524364
-
Harnessing preclinical mouse models to inform human clinical cancer trials
-
Gutmann D, Hunter-Schaedle K, Shannon K. Harnessing preclinical mouse models to inform human clinical cancer trials. J Clin Invest 2006;116(4):847-852
-
(2006)
J Clin Invest
, vol.116
, Issue.4
, pp. 847-852
-
-
Gutmann, D.1
Hunter-Schaedle, K.2
Shannon, K.3
-
83
-
-
27644517404
-
The HMG-CoAreductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1
-
Li W, Cui Y, Kushner S, et al. The HMG-CoAreductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol 2005;15(21):1961-1967
-
(2005)
Curr Biol
, vol.15
, Issue.21
, pp. 1961-1967
-
-
Li, W.1
Cui, Y.2
Kushner, S.3
-
84
-
-
47549111338
-
Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: A randomized controlled trial
-
Krab L, De Goede-Bolder A, Aarsen F, et al. Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. JAMA 2008;300(3):287-294
-
(2008)
JAMA
, vol.300
, Issue.3
, pp. 287-294
-
-
Krab, L.1
De Goede-Bolder, A.2
Aarsen, F.3
-
85
-
-
49949110162
-
Modelling neurofibromatosis type 1 tibialdysplasia and its treatment with lovastatin
-
Kolanczyk M, Kuhnisch J, Kossler N, et al. Modelling neurofibromatosis type 1 tibialdysplasia and its treatment with lovastatin. BMC Med 2008;6:21
-
(2008)
BMC Med
, vol.6
, pp. 21
-
-
Kolanczyk, M.1
Kuhnisch, J.2
Kossler, N.3
-
86
-
-
70349498475
-
Skeletal abnormalities in neurofibromatosis type 1: Approaches to therapeutic options
-
Elefteriou F, Kolanczyk M, Schindeler A, et al. Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options. Am J Med Genet A 2009;149A(10):2327-2338
-
(2009)
Am J Med Genet A
, vol.149 A
, Issue.10
, pp. 2327-2338
-
-
Elefteriou, F.1
Kolanczyk, M.2
Schindeler, A.3
-
87
-
-
44449093081
-
TORC1 is essential for NF1-associated malignancies
-
Johannessen C, Johnson B, Williams S, et al. TORC1 is essential for NF1-associated malignancies. Curr Biol 2008;18(1):56-62
-
(2008)
Curr Biol
, vol.18
, Issue.1
, pp. 56-62
-
-
Johannessen, C.1
Johnson, B.2
Williams, S.3
-
88
-
-
77952668952
-
RNA splicing meets genetic testing: Detection and interpretation of splicing defects in genetic diseases
-
In press
-
Tosi M, Stamm S, Baralle D. RNA splicing meets genetic testing: detection and interpretation of splicing defects in genetic diseases. Eur J Hum Genet 2010; In press
-
(2010)
Eur J Hum Genet
-
-
Tosi, M.1
Stamm, S.2
Baralle, D.3
-
89
-
-
34548136083
-
Detection of copy number changes at the NF1 locus with improved high-resolution array CGH
-
Shen M, Mantripragada K, Dumanski J, et al. Detection of copy number changes at the NF1 locus with improved high-resolution array CGH. Clin Genet 2007;72(3):238-244
-
(2007)
Clin Genet
, vol.72
, Issue.3
, pp. 238-244
-
-
Shen, M.1
Mantripragada, K.2
Dumanski, J.3
-
90
-
-
70350452927
-
Detection and characterization of NF1 microdeletions by custom high resolution array CGH
-
Pasmant E, Sabbagh A, Masliah-Planchon J, et al. Detection and characterization of NF1 microdeletions by custom high resolution array CGH. J Mol Diagn 2009;11(6):524-529
-
(2009)
J Mol Diagn
, vol.11
, Issue.6
, pp. 524-529
-
-
Pasmant, E.1
Sabbagh, A.2
Masliah-Planchon, J.3
-
91
-
-
52949096084
-
Next-generation DNA sequencing methods
-
Mardis E. Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet 2008;9:387-402
-
(2008)
Annu Rev Genomics Hum Genet
, vol.9
, pp. 387-402
-
-
Mardis, E.1
-
92
-
-
73449142861
-
DNA sequence capture and enrichment by microarray followed by next-generation sequencing for targeted resequencing: Neurofibromatosis type 1 gene as a model
-
Chou L, Liu C, Boese B, et al. DNA sequence capture and enrichment by microarray followed by next-generation sequencing for targeted resequencing: neurofibromatosis type 1 gene as a model. Clin Chem 2010;56(1):62-72
-
(2010)
Clin Chem
, vol.56
, Issue.1
, pp. 62-72
-
-
Chou, L.1
Liu, C.2
Boese, B.3
-
93
-
-
52949127312
-
An integrated genomic analysis of human glioblastomamultiforme
-
Parsons D, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastomamultiforme. Science 2008;321(5897):1807-1812
-
(2008)
Science
, vol.321
, Issue.5897
, pp. 1807-1812
-
-
Parsons, D.1
Jones, S.2
Zhang, X.3
-
94
-
-
54549094903
-
Somatic mutations affect key pathways in lung adenocarcinoma
-
Ding L, Getz G, Wheeler D, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008;455(7216):1069-1075
-
(2008)
Nature
, vol.455
, Issue.7216
, pp. 1069-1075
-
-
Ding, L.1
Getz, G.2
Wheeler, D.3
-
95
-
-
57349132432
-
Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations
-
Sangha N, Wu R, Kuick R, et al. Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations. Neoplasia 2008;10(12):1362-1372
-
(2008)
Neoplasia
, vol.10
, Issue.12
, pp. 1362-1372
-
-
Sangha, N.1
Wu, R.2
Kuick, R.3
-
96
-
-
77952420655
-
AML with CBFB-MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletions
-
Haferlach C, Dicker F, Kohlmann A, et al. AML with CBFB-MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletions. Leukemia 2010;24:1065-1069
-
(2010)
Leukemia
, vol.24
, pp. 1065-1069
-
-
Haferlach, C.1
Dicker, F.2
Kohlmann, A.3
-
97
-
-
33645061486
-
Large-scale molecular comparison of human Schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues
-
Miller S, Rangwala F, Williams J, et al. Large-scale molecular comparison of human Schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues. Cancer Res 2006;66:2584-2591
-
(2006)
Cancer Res
, vol.66
, pp. 2584-2591
-
-
Miller, S.1
Rangwala, F.2
Williams, J.3
-
98
-
-
33746895189
-
Identification of a novel amplicon at distal 17q containing the BIRC5/ SURVIVIN gene in malignant peripheral nerve sheath tumours
-
Storlazzi C, Brekke H, Mandahl N, et al. Identification of a novel amplicon at distal 17q containing the BIRC5/ SURVIVIN gene in malignant peripheral nerve sheath tumours. J Pathol 2006;209(4):492-500
-
(2006)
J Pathol
, vol.209
, Issue.4
, pp. 492-500
-
-
Storlazzi, C.1
Brekke, H.2
Mandahl, N.3
-
99
-
-
67650095150
-
Ral overactivation in malignant peripheral nerve sheath tumors
-
Bodempudi V, Yamoutpoor F, Pan W, et al. Ral overactivation in malignant peripheral nerve sheath tumors. Mol Cell Biol 2009;29(14):3964-3974
-
(2009)
Mol Cell Biol
, vol.29
, Issue.14
, pp. 3964-3974
-
-
Bodempudi, V.1
Yamoutpoor, F.2
Pan, W.3
-
100
-
-
47349087197
-
DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH
-
Kresse S, Skarn M, Ohnstad H, et al. DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH. Mol Cancer 2008;7:48
-
(2008)
Mol Cancer
, vol.7
, pp. 48
-
-
Kresse, S.1
Skarn, M.2
Ohnstad, H.3
-
101
-
-
75449103584
-
Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene
-
Miller S, Jessen W, Mehta T, et al. Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. EMBO Mol Med 2009;1(4):236-248
-
(2009)
EMBO Mol Med
, vol.1
, Issue.4
, pp. 236-248
-
-
Miller, S.1
Jessen, W.2
Mehta, T.3
-
102
-
-
34047096557
-
Cancer stem cells: Models and concepts
-
DOI 10.1146/annurev.med.58.062105.204854
-
Dalerba P, Cho R, Clarke M. Cancer stem cells: models and concepts. Annu Rev Med 2007;58:267-284 (Pubitemid 46706514)
-
(2007)
Annual Review of Medicine
, vol.58
, pp. 267-284
-
-
Dalerba, P.1
Cho, R.W.2
Clarke, M.F.3
-
103
-
-
41149100145
-
MicroRNA expression signature of human sarcomas
-
Subramanian S, Lui W, Lee C, et al. MicroRNA expression signature of human sarcomas. Oncogene 2008;27(14):2015-2026
-
(2008)
Oncogene
, vol.27
, Issue.14
, pp. 2015-2026
-
-
Subramanian, S.1
Lui, W.2
Lee, C.3
-
104
-
-
73649129263
-
Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours
-
Subramanian S, Thayanithy V, West R, et al. Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours. J Pathol 2010;220(1):58-70
-
(2010)
J Pathol
, vol.220
, Issue.1
, pp. 58-70
-
-
Subramanian, S.1
Thayanithy, V.2
West, R.3
-
105
-
-
64649097659
-
[18F] FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1
-
Warbey V, Ferner R, Dunn J, et al. [18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1. Eur J Nucl Med Mol Imaging 2009;36(5):751-757
-
(2009)
Eur J Nucl Med Mol Imaging
, vol.36
, Issue.5
, pp. 751-757
-
-
Warbey, V.1
Ferner, R.2
Dunn, J.3
-
106
-
-
61649121051
-
Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations
-
Pros E, Fernandez-Rodriguez J, Canet B, et al. Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations. Hum Mutat 2009;30(3):454-462
-
(2009)
Hum Mutat
, vol.30
, Issue.3
, pp. 454-462
-
-
Pros, E.1
Fernandez-Rodriguez, J.2
Canet, B.3
-
107
-
-
65849111219
-
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells
-
Scholl C, Frohling S, Dunn I, et al. Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell 2009;137(5):821-834
-
(2009)
Cell
, vol.137
, Issue.5
, pp. 821-834
-
-
Scholl, C.1
Frohling, S.2
Dunn, I.3
|